Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3345-3351

  Molnar, Miklos Z ^a,b   Bunnapradist, Suphamai ^c   Huang, Edmund ^c   Krishnan, Mahesh ^d   Nissenson, Allen R ^c,d   Kovesdy, Csaba P ^e,f   Kalantar Zadeh, Kamyar ^a,g  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DAVITA INC   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anemia; erythropoietin stimulating agent therapy; graft failure; kidney transplantation; mortality

Indexed keywords

HEMOGLOBIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREMEDICATION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK ASSESSMENT;

ADULT; COHORT STUDIES; DATABASES, FACTUAL; DELAYED GRAFT FUNCTION; DRUG RESISTANCE; FEMALE; GRAFT REJECTION; HEMATINICS; HUMANS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84864619240     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs064     Document Type: Article

References (27)

1. Li S, Foley RN, Collins AJ. Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States. Kidney Int 2004; 65: 1864-1869.
2. Regidor DL, Kopple JD, Kovesdy CP et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17: 1181-1191.
3. Molnar MZ, Czira M, Ambrus C et al. Anemia is associated with mortality in kidney-transplanted patients-a prospective cohort study. Am J Transplant 2007; 7: 818-824.
4. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K et al. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 2006; 69: 560-564.
5. Kaysen GA, Muller HG, Ding J et al. Challenging the validity of the EPO index. Am J Kidney Dis 2006; 47: 166.
6. Zhang Y, Thamer M, Stefanik K et al. Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 2004; 44: 866-876.
7. Solomon SD, Uno H, Lewis EF et al. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 2010; 363: 1146-1155.
8. Bradbury BD, Brookhart MA, Winkelmayer WC et al. Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations. Am J Kidney Dis 2009; 54: 554-560.
9. Bradbury BD, Danese MD, Gleeson M et al. Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL. Clin J Am Soc Nephrol 2009; 4: 630-637.
10. Berns JS. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?. Curr Opin Nephrol Hypertens 2010; 19: 567-572.
11. Streja E, Kovesdy CP, Greenland S et al. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 2008; 52: 727-736.
12. Kalantar-Zadeh K, Lee GH, Miller JE et al. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 2009; 53: 823-834.
13. Kalantar-Zadeh K, McAllister CJ, Lehn RS et al. Effect of malnutrition- inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003; 42: 761-773.
14. Molnar MZ, Tabak AG, Alam A et al. Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol 2011; 6: 2879-2886.
15. Campise M, Mikhail A, Quaschning T et al. Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival. Nephrol Dial Transplant 2005; 20; (Suppl 8): viii8-viii12.
16. Gomez-Alamillo C, Fernandez-Fresnedo G, Ortega F et al. Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study. Transplant Proc 2010; 42: 2935-2937.
17. Duong U, Mehrotra R, Molnar MZ et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 2011; 6: 1041-1048.
18. Molnar MZ, Kovesdy CP, Bunnapradist S et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant 2011; 11: 1006-1015.
19. Miller JE, Kovesdy CP, Nissenson AR et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 2010; 55: 100-112.
20. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008; 23: 2995-3003.
21. Shinaberger CS, Greenland S, Kopple JD et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am J Clin Nutr 2008; 88: 1511-1518.
22. Molnar MZ, Streja E, Kovesdy CP et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant 2011; 11: 725-736.
23. Lopez-Gomez JM, Portoles JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl 2008; S75-S81.
24. Molnar MZ, Czira ME, Rudas A et al. Association of the malnutrition- inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis 2011; 58: 101-108.
25. Molnar MZ, Keszei A, Czira ME et al. Evaluation of the malnutrition- inflammation score in kidney transplant recipients. Am J Kidney Dis 2010; 56: 102-111.
26. Szczech LA, Barnhart HX, Sapp S et al. A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. Kidney Int 2010; 77: 239-246.
27. Perico N, Cattaneo D, Sayegh MH et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827